| Logo | Name | Σ | Employees |
|---|---|---|---|
 | AFFICHEM AFTERM is a medicinal chemistry company that develops innovative molecules for therapeutic for cancer and hearing loss, as well as innovative active ingredients in the field of dermo-cosmetics. Playing is a medicinal chemistry company that development innovative therapeutic molecules against cancer and hearing loss, as well as innovative active ingredients in the field of dermo-cosmetics. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 1 |
 |  BLSI - Brussels Life Science Incubator Achieve your dream of an innovative, durable business The business incubator BLSI – Brussels Life Science Incubator – supports young entrepreneurs in the creation of innovative activities and promotes the valorisation of scientific research, specifically in the life sciences and health sector. Most of the projects supported are in e-health, medical devices, and biotechnology. However, BLSI remains open to other technological sectors because this greatly benefits the innovative process and the emergence of creative solutions. The specific incubation concept consists of simultaneously offering the provision of modern and equipped administrative premises and laboratory areas, personalized strategic support, as well as … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 5 | 5 |
 | EUCOPE - European Confederation of Pharmaceutical Entrepreneurs The trade association giving a bigger voice to small and mid-sized innovative health technology companies in Europe For 15 years, the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) has been the voice of small to mid-sized health technology companies in Europe. As a trade association, we advocate for sound public policy that supports innovation, while fostering a community built on a shared purpose: improving and saving the lives of European patients through innovative therapies and medical technology. EUCOPE’s members – who represent over 2600+ innovative companies directly or via associations – are researching, designing, developing, supplying, manufacturing, and deploying the next … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech healthtech | 20 | 21 |
 | DBV Technologies On a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians who believed that food allergies could one day be treated safely and effectively. We are on a mission to advance epicutaneous immunotherapy using our innovative technology platform, ViaskinTM, to develop treatment options for immunologic diseases with significant unmet medical need. This mission drives our commitment to the advancement of treatments for patients and their families. That is why we are investigating a potential new class of immunotherapy, epicutaneous immunotherapy (EPIT), that aims to re-educate the … | 6 | 187 |
 | PhysioStim Nonclinical expert in cardiovascular pharmacology & electrophysiology and vascular functions PhysioStim is a French preclinical CRO dedicated to cardiovascular pharmacology and electrophysiology from discovery stages to clinical development. Whatever the therapeutic areas, we ensure robust and valuable preclinical data on cardiac and vascular activities and secondary pharmacology to secure in-vivo development and bring new safe therapies to patients. Thanks to our predictive and translational models, we define the POC of drug discovery, we investigate secondary pharmacology with on and off-target liabilities, and we address the safety purpose to build and support your IND submission (with mandatory and not mandatory assays). … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 3 | 11 |
 | Kropz Elandsfontein Responsible rock phosphate exploration, mining and processing. Focused on responsible rock phosphate exploration, mining and processing. Our mission is to set a new standard in the green mining of fertiliser feed minerals and to develop a world class plant nutrient fertiliser production and distribution capacity that will meaningfully contribute towards feeding sub-Saharan Africa for generations to come. Due to the low cadmium and other heavy metal content of Kropz Elandsfontein’s rock phosphate is also a member of Safer Phosphates. Phosphate Mining and SA's second largest Phosphate deposit | 0 | 10 |
 |  Memo Therapeutics AG Memo Therapeutics AG (“MTx”) is a late-stage biotech company translating unique human immune responses into superior medicines through the development of best-in-class antibodies to treat viral infections and cancer. The Company’s lead program, Potravitug, is in Phase II development targeting BK viremia (BKV) in kidney transplant recipients, an infection which can result in decreased kidney functionality and longevity and reduced patient survival. Potravitug has the potential to become the best and first-in-class BKV disease-modifying therapy for kidney transplant patients. Alongside Potravitug, MTx is focused on discovering novel antibody-target pairs for oncology based on tumor infiltrating B-cells derived leveraging tertiary lymphoid … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 44 |
 | VarmX VarmX is a young biotech company focusing on the development of therapies in the field of hemostasis and thrombosis. VarmX (www.varmx.com) is a young Leiden based biotech company that is focusing on the development of therapies in the field of hemostasis and thrombosis. Originally a spin-off from the Leiden University Medical Center (LUMC), our mission is to develop and manufacture therapeutic proteins to restore hemostasis. Our lead compound, VMX-C001, is intended to safely and effectively restore hemostasis in case of bleeding or emergency surgery in patients taking so-called oral factor Xa inhibitors. The VarmX program has gained significant interest in … Type: Startup Activities: manufacturing deeptech biotech healthtech Technologies: Synthetic Biology | 3 | 26 |
 | Minervax ApS Developing a maternal vaccine for Group B Streptococcus MinervaX is pursuing the development of a maternal vaccine for the prevention of adverse pregnancy outcomes and life-threating infections caused by Group B streptococcus (GBS). The vaccine is based on adjuvanted proteins antigens covering close to 100% of clinical GBS isolates. Group B Streptococcal (GBS) is the leading cause of life-threatening infections in newborns. Colonization of pregnant women with GBS may lead to adverse pregnancy outcomes such as late abortions, stillbirths, and preterm delivery. Colonization may also lead to life-threatening infections in newborns for the first 3 months of life, causing pneumonia, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 68 |
 | MoonLake Immunotherapeutics (NASDAQ: MLTX) Creating next-level therapies for inflammatory skin and joint diseases with Nanobody® science MoonLake Immunotherapeutics AG is a clinical-stage biopharmaceutical company leveraging revolutionary Nanobody® technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases. Immunotherapy, inflammatory skin & joint diseases, partnering, IL17A / F, #MLTX, #Nanobody, #HS, #PsA, and #IL17 | 3 | 115 |
 | Acousia Therapeutics GmbH Enhance & Preserve Natural Hearing ! Acousia is a pioneer of novel medicines. Founded in 2012, the company’s experienced and entrepreneurial management team is committed to combating hearing loss. Thanks to its exclusive collaboration agreement with the renowned Translational Hearing Research Group of Tuebingen University Clinic and an ecosystem of experts and CROs, Acousia has made significant strides with its advanced small molecule drug candidates. Hearing Loss Treatment and Hearing Loss Drug Development Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 5 |
 | MolDrug Chemoinformatics and modeling solutions to optimize your drug candidates. MolDrug (a ProtoQSAR company) is a group specializing in the design and optimization of molecules through Machine Learning-powered chemoinformatics and structural bioinformatics. Our models allow for the prediction of molecular properties (QSAR) and detailed interaction analyses (molecular modelling). We work with all types of compounds, including small molecules, peptides, nanomaterials, mixtures... Our tools allow for the prediction and assessment of physicochemical, biological, pharmacological, and/or (eco)toxicological properties of substances with an array of advantages: - faster results - saving money and resources - reduce animal testing (3 Rs) - regulatory validity (REACH, … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 0 | 4 |
 | Relation Discovering the relationships at the heart of biology to cure disease. We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell and multi-omics measurements directly from patient tissue, functional assays and machine learning to drive disease understanding — from cause to cure. Medicines born from high-resolution biology, machine learning and clinical insights. Our Lab-in-the-Loop seamlessly integrates single-cell analysis, genomics and machine learning. We have developed powerful technologies which we apply to select … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 14 | 86 |
 | LDMH Partners Life Sciences Advisors. UK | EU | North America We are a niche life sciences advisory firm, and a full service law firm, with exceptional expertise in human tissue- and cell-based research, clinical care, and assisted reproduction. We advise established biotechnology companies as well as start-ups, fertility clinics, and biobanks. medical ethics, data protection, medical law, autonomy, biotechnology, clinical trials, consent, GDPR, Law, and Life sciences law Type: Startup Activities: biotech deeptech privacytech legaltech Technologies: Synthetic Biology | 0 | 7 |
 | Crafting Future Wir produzieren nachhaltige Mehrwegbehälter und entwickeln gemeinsam die für dich passende Mehrweglösung Disposable waste is one of the biggest problems of our time. At the same time we know that there will never be a world without plastics. That is why we have made it our mission to question the plastics industry. In our material selection, product design and product development, we place a special focus on the end of a product's life cycle. In doing so, we consider the recovery of an equivalent amount of plastic compared to the amount used in manufacturing. We develop our own reusable products … Type: Startup Activities: biotech manufacturing Technologies: New Materials | 5 | 10 |
 | NewClin We build patients’ Health Determinome for you. Increase the performance of your care and clinical research journeys NewClin develops a data-driven and AI-powered game-changing SaaS B2B platform to automatically contextualize patients' health data with their non-medical (social, behavioral, environmental) determinants of health. It allows the production of new patient-, cohort- and population-related predictive and prognostic markers, including a unique patient's Health Determinome, paving the way for precision interventions and precision prevention. Our ambition is to transform decisions from industry, healthcare providers, researchers, and payors in order to decrease the cost and increase the performance or healthcare and clinical research and … Type: SMB Activities: biotech deeptech healthtech Technologies: A.I. | 14 | 7 |
 | Median Technologies Median Technologies provides innovative imaging solutions and services to advance healthcare for everyone. We harness the power of medical images by using the most advanced Artificial Intelligence technologies, to increase the accuracy of diagnosis and treatment of many cancers and other metabolic diseases at their earliest stages and provide insights into novel therapies for patients. Our iCRO solutions for medical image analysis and management in oncology trials and eyonisTM, our AI/ML tech-based suite of software as medical devices (SaMD) help biopharmaceutical companies and clinicians to bring new treatments and diagnose patients earlier and more accurately. This is how we are … Type: SMB Activities: biotech deeptech it services Technologies: A.I. A.I. - Deep Learning A.I. - Image Processing Data Analytics | 25 | 218 |
 | VUS Diagnostics VUS Diagnostics is a company that understand the functional impact of gene variants in genetic disease including cancers. | 0 | 10 |
 | Sycai Medical We empower radiologists in the non invasive fight against #Cancer through AI and big data based algorithms Our #AI and #BigData based software assists radiologists in the detection and characterization of abdominal lesions on CT scans and MRIs. It also provides a prediction of the probability of each lesion to become cancer in the future, which is crucial to diagnose early-stage pancreatic cancer and to improve the life quality of patients deep learning, software, computer vision, medical imaging, convolutional networks, AI, artificial intelligence, diagnosis, MedTech, and Digital Health Type: Startup Activities: deeptech healthtech biotech Technologies: A.I. A.I. - Deep Learning | 9 | 17 |
 | 4D Lifetec AG First Swiss Liquid Biopsy for the early detection of cancer based on a new innovative transformational biomarker About 4D Lifetec AG 4D Lifetec is a pioneer on a mission to revolutionize early cancer detection. Our easy and powerful blood tests can detect cancer at its earliest stages (I and II), offering you peace of mind and proactive well-being protection. Sophisticated artificial intelligence (AI) enhances our immunological high-throughput blood assays which in turn enables timely intervention and treatment. Molecular Diagnostics, Oncology, Genotoxicity, DNA Damage and Repair, Liquid Biopsy, Biomarker, Early cancer detection, Early cancer diagnosis, Cancer test, Lung Cancer, and Bronchoscopy Type: Startup Activities: deeptech biotech Technologies: A.I. | 0 | 3 |
 | Tessellate BIO Redefining Synthetic Lethality beyond HRD Tessellate BIO discovers and develops novel precision oncology medicines with the mission to turn cancer patients into cancer survivors. A private preclinical stage biotechnology company, Tessellate BIO is redefining Synthetic Lethality by developing drugs that target unexplored or difficult to drug pathways beyond HRD. Headquartered in the Netherlands and with research labs at the Stevenage Bioscience Catalyst, UK, Tessellate BIO is supported by top-tier life science investors BioGeneration Ventures (BGV) and Forbion. drug discovery, precision oncology, and biotechnology Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 29 |
 | Cirdan Ltd Leading provider of informatics software and imaging solutions that enhance and speed up the diagnosis of patients. Cirdan designs, manufactures and supplies innovative software and imaging solutions for the acceleration and enhancement of diagnosis. Our systems are optimised for pathology and clinical laboratory usage. Cirdan’s primary product is its world-class Laboratory Information System, ULTRA. ULTRA has been designed to streamline laboratory operations and is currently installed in more than 72 laboratories across 6 continents. Another core product is PathLite Compact, a purpose-built system designed specifically for gross imaging within clinical laboratories. The company was founded in 2010 and is headquartered … Type: Startup Activities: manufacturing deeptech biotech healthtech Technologies: Synthetic Biology | 4 | 118 |
 | Bentley Development & manufacture of innovative endovascular products for the treatment of peripheral vascular & aortic disease. Bentley’s passion is the development, manufacturing and marketing of innovative implants for minimal-invasive treatments of vascular diseases. Bentley was founded in 2009 by medical entrepreneurs Lars Sunnanväder and Miko Obradovic. The company has seen substantial growth since the launch of its first product in 2012. Since then Bentley rapidly expanded worldwide. Thanks to its international network of exclusive distribution partners Bentley is represented in more than 80 countries – in some even as market leader. Bentley is the only company worldwide that offers a … Type: Startup Activities: manufacturing deeptech biotech | 2 | 260 |
 | Egetis Therapeutics AB Pharmaceutical drug development company, focusing on late-stage development for treatment of serious rare diseases. Egetis is an innovative and integrated pharmaceutical company, focusing on projects in late-stage development for commercialization for treatments of serious diseases with significant unmet medical needs in the orphan drug segment Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 49 |
 | Laminar Pharma Biopharmaceutical company performing discovery, rational design and initial clinical development of new MLT-based drugs. Laminar Pharma is a pioneering biopharmaceutical company that focuses on the discovery, rational design and development of a new generation of medicines that act through the innovative therapeutic strategy known as “Membrane-Lipid Therapy” (MLT). Laminar Pharma arose in 2006 as an academic spin-off to commercially develop new scientific know-how and applications generated by leading scientists at the University of the Balearic Islands (UIB) in Mallorca, Spain, headed by Prof. Pablo V. Escriba. Laminar Pharma aims to develop next-generation medicines, nutraceutical and cosmetic products based on the … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 37 |
 | RoukenBio We provide drug developers with high-quality data to give them the confidence to take their drug discovery forward. RoukenBio – CRO redefined. RoukenBio takes its tagline seriously - disrupting the traditional CRO model with a collaborative, personalised approach to drug discovery. With customers in over 27 countries, RoukenBio aims to become the most trusted research partner to biotherapeutic innovators globally. Backed by brilliant minds, RoukenBio offers a range of in vitro drug discovery services with specialist expertise across human immunology, bioanalytical, cell line engineering, molecular biology, bioassay development and safety and efficacy assessments. RoukenBio partners with therapeutic developers from early … Type: Startup Activities: biotech deeptech Technologies: Data Analytics | 0 | 88 |
 | Onena Medicines AI-centric preclinical company discovering and developing novel biopharmaceuticals to treat cancer and rare diseases Onena Medicines is a biopharmaceutical company with a pipeline of first-in-class antibody medicines to treat recurrent and metastatic cancers and selected rare diseases. Onena’s drugs neutralize a new class of secreted ancient growth factors, conserved across species, called Dual SMAD Inhibiting Proteins (DSIPs), that program cancer cells to grow and resist chemotherapy. Blocking DSIPs, as demonstrated in-vivo by Onena, simultaneously reactivates physiological TGF-β and BMP signaling and elicits cellular reprogramming, resulting in cancer cells accepting environmental cell death signals from BMPs and Activins. Onena has developed … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology A.I. | 0 | 13 |
 | ARTICA Therapeutics Development of covalent small molecules to transform the treatment of autoimmune and inflammatory disorders ARTICA Therapeutics and its seasoned team started operatons in 2020 and was supported by pre-Seed financing from BioGeneration Ventures. Artica is dedicated to developing novel small molecule medicines for inflammatory and autoimmune indicatons. Artca is at the forefront of covalent binding technology as well as in label-free cellular-based screening approaches. The unique combinaton of these capabilities allows rapid progression of the best drug candidates that have unprecedented and superior characteristics, creating novel and highly selective therapies for patients with unmet medical need. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 17 |
 | Synerkine Pharma Creating Innovative Pain Solutions Synerkine Pharma B.V. focuses on development of novel fusion proteins, called Synerkines, that combine the immunoregulatory activity of different cytokines. These fusion proteins have unique benefits over the individual cytokines and modulate a broad number of targets, including key elements in the pain pathway. This provides treatment options for chronic pain conditions with a clearly differentiated mechanism of action over current analgesic drugs and holds tremendous therapeutic and commercial potential. Synerkine Pharma B.V. was founded in 2018 as a spin-off of the University Medical Center Utrecht (UMCU), the Netherlands. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 9 |
 | TrackPaw Scientific AB We digitalise preclinical studies to increase welfare and research quality. TrackPaw Scientific's deep tech solution for 24/7 monitoring of early stage pharmaceutical development offers improved animal welfare together with better study outcomes. Biotechnology , Drug development, Machine learning, Artificial Intelligence, Deep tech, Preclinical research, Animal welfare, and 3R Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 10 |
 | Cellsway Cellsway is a fresh deep-tech start-up founded in March 2020 in UK to convert the know-how and cutting-edge core technology that have been developed and cultivated at Mikro Biyosistemler Inc. into commercial products to set the gold standard for diagnosis and management of cancer. The flagship product of the company is a liquid biopsy platform which uses a simple blood sample for cancer diagnostics and cancer research. The patent-pending microfluidic technology enables isolation and enumeration of Circulating Tumor Cells (CTCs) from the blood samples of cancer patients. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 4 | 6 |
 | Coriolis Pharma Science Driven Development and Analytical Support - From Early Development to Commercialization. Coriolis Pharma is a globally operating and science driven contract research and development organization (CRDO). We support drug product development of biopharmaceuticals, including gene and cell therapies and vaccines, from early development to commercialization. Our focus lies on formulation development, lyophilization technologies and analytics (GMP and non-GMP) for a wide range of products. As a privately held and independent company with an interdisciplinary team of highly skilled scientists and an expert scientific advisory board, we provide cutting-edge services and tailor-made solutions for our clients. We offer a large … Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 170 |
 | ResoTher Pharma Building on innovative science to create treatments for patients in need ResoTher Pharma ApS is a biotechnology company focused on developing novel and effective peptide therapeutics for cardiovascular disease by targeting inflammation. Biotechnology, Drug Development, and Pharmaceutical Industry Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 17 |
 | Pixelgen Technologies Protein interactomics by Proximity Networks® of single cells Pixelgen Technologies AB is on a mission to deliver biology at the highest resolution by understanding the molecular basis of cellular function with new tools and technologies that decipher the protein interactomics of single cells in unprecedented ways. The company’s patented Proximity Network Assay delivers nanoscale spatial analysis of immune cell proteins at ultra-high capacity and underpins the Pixelgen Proxiome Kit for precision medicine. A foundational technology, the Proximity Network Assay will power a portfolio of products for translational research to accelerate advances in immunology, hematology, and cell therapy. Pixelgen was founded … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 30 |
 | Da Volterra Clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiome field. Da Volterra is a clinical stage biotechnology company whose vision is to be a trusted and acknowledged leader in the microbiota field. Our mission is to discover, develop and bring to market safe and novel therapeutic options, preserving patients’ microbiota to prevent and cure life-threatening diseases. We strive to serve patients by transforming the promise of science into innovative treatments which have the power to improve health and save lives. Committed to innovation, Da Volterra develops products intended to protect the intestinal … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 9 |
 | LimmaTech Biologics AG Better technology for better health LimmaTech Biologics AG is a Swiss-based clinical stage biopharmaceutical company. We are advancing our proprietary vaccine pipeline to halt the increasing threat of global infections due to emerging antibiotic resistance (AMR) and sexually transmitted diseases. In addition to our proprietary research, we also develop vaccines together with GSK. vaccines, research & development, biotechnology, and antimicrobial resistance Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 1 | 50 |
 | Agomab Agomab is translating a deep expertise in growth factor biology to pioneer and develop novel treatments that aim to resolve fibrosis, repair tissue structure and restore organ function. Combining new scientific insights with robust drug development and a long-term corporate vision, we are building a broad clinical pipeline of differentiated programs with disease modifying potential in severe organ failure and fibrotic diseases. Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 49 |
 | ADOR Diagnostics Molecular Diagnostics Innovations ADOR Diagnostics is an innovative IVD company that specializes in the development of cutting-edge syndromic multiplex molecular biology diagnostics technology. ADOR sets a new standard by revolutionizing the way laboratories worldwide diagnose infectious diseases with multiplex,sample-to-answer, fully automated systems that deliver accurate results rapidly. By using ADOR’s systems, laboratories can reduce costs and increase efficiency while doctors are able to treat patients with confidence, knowing they would prescribe the correct antibiotics and the right treatment. The NATlab system is a multiplex isothermal (RCA) based cutting-edge molecular biology platform with a bench-top modular analyzer and a disposable all-included … Type: Startup Activities: biotech deeptech healthtech Technologies: SaaS | 0 | 13 |
 | AstronauTx AstronauTx is tackling dementia through improving brain physiology AstronauTx is at the forefront of a novel approach to treating neurodegenerative diseases. We have a unique portfolio of small-molecule therapeutics to restore dysregulated physiology to both improve symptoms and modify disease. Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 2 | 15 |
 | Takodana Portugal Takodana Portugal is a medical cannabis company, based in Portugal, licensed by the portuguese regulator - INFARMED. Takodana Portugal is a licensed medical cannabis company based in Portugal. We specialize in cultivating premium-quality cannabis, leveraging cutting-edge technology and the expertise of a dedicated, experienced team to ensure the highest standards in every step of the process. Type: SMB Activities: biotech deeptech healthtech manufacturing | 23 | 6 |
 | Kappa Santé CRO specializing in real life data Kappa Health was born from the desire to provide quality services in the fields of epidemiology, pharmaco-epidemiology and public and digital health interventions. The company was founded at the end of 2002 and is based in Paris KAPPA Santé is an independent CRO, a member of the ENCPPP (European Network of Centers for Pharmacoepidemiology and Pharmacovigilance), AFCRO (French Association of CRO), Oséo Excellence (Community of Entrepreneurs chosen by Oséo) and the Cap Digital competitiveness cluster. Today we have participated in more than 100 studies in many therapeutic areas Public health, pharmaco-epidemiology, medical devices, intervention … Type: SMB Activities: healthtech biotech deeptech Technologies: Synthetic Biology | 9 | 41 |
 | Prestwick Chemical Libraries We design and offer a range of smart chemical libraries to ensure a high hit rate Prestwick Chemical is a French provider of smart libraries. For almost 20 years, the company, founded by Prof. Camille-Georges Wermuth, has provided medicinal chemistry services and screening libraries to accelerate small molecules drug discovery. Prestwick has a large portfolio of smart Libraries designed to ensure maximal chemical diversity, possibly to access new IP while remaining within reach of both low and high throughput screening processes. They are constantly updated and improved. Our clients have reported high quality hit generation rate. The Prestwick Chemical Library®, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 7 |
 | ViewPoint Behavior Technology Pioneer and leader in videotracking tools for animal behavior analysis ViewPoint is the precursor of behavioral tracking for zebrafish and rodents. Established in 1990, ViewPoint was the first to offer automated tracking of behavior for rodents. Our solutions give access to high throughput screening, reliable data, better time and cost efficiency and ground-breaking studies. Large-scale screening studies were previously prohibitively expensive and time-consuming, now with ViewPoint’s tools, research is driven forward at an unprecedented rate. There are many other advantages to automated behavioral tracking. Unlike manual observation, behaviors are recorded consistently each time, human uncertainty is excluded. Automated video tracking … Type: SMB Activities: biotech deeptech Technologies: A.I. A.I. - Image Processing Data Analytics | 7 | 15 |
 | PHOENIX Pharma France Your Pharmaceutical Document Partner on a daily basis Phoenix, family group, free and independent. Phoenix Pharma is a wholesaler-pharmaceutical response and solutions provider for pharmacies. French subsidiary of the Phoenix group present in 29 European countries and bringing together around 45,000 employees, it provides pharmacies with more than 40,000 product references in France. Our expertise is to deliver the right product, in the right place and at the right time. Each day in France, more than 800 employees unite their energy so that each patient can access their treatment as soon as possible. It is through its logistics performance and … | 3 | 418 |
 | BIO-MODELING SYSTEMS The Mechanisms-Based Medicine Company Bio-Modeling Systems is the world’s first Mechanisms-Based medicine company that changed the discovery paradigm to create novel medical meanings from unreliable heterogeneous sources of data to generate validated & directly exploitable first in class heuristic non-mathematical mechanistic CADITM Discovery models. We propose to R&D & Translational Medicine Executives, robust alternative decision-making to de-risk, save time, costs, and novel cost-effective diagnostics/therapies for their businesses. Created in 2004, profitable since 2006, thanks to our recurrent clients, we confirmed with our partners CADITM Discovery capability to generate outstanding value through: • Strong & long term strategic R&D collaborations (>100 … Type: SMB Activities: healthtech deeptech biotech Technologies: A.I. | 10 | 5 |
 | Roche Farma España For us patients are first. The second, too. Roche Farma is a leading company in the health sector, focused on the research and development of medicines and products for diagnosis in order to advance science and improve people's lives. Roche is the largest biotechnology in the world and has significantly differentiated medications in the areas of oncology, immunology, infectious diseases, ophthalmology and neurosciences. He is also a world leader in vitro diagnosis, including the histological diagnosis of cancer, and is located at the forefront of diabetes control. Oncology, immunotherapy, neurosciences, diagnoses, diabetes, and pharmaceutical industry | 4 | 438 |
 | Eurofins Genomics The DNA Universe Eurofins Genomics was founded in 1990 and is part of the Eurofins Scientific Group, a Life Science Company with laboratories in 61 countries and 61,000 employees. We are an international provider of genomic services around the core business lines next generation sequencing, genotyping, gene expression, custom DNA sequencing, oligonucleotides, siRNA and gene synthesis. Our services are tailored for pharma, diagnostics, agriculture, food, biotechnology and research applications worldwide. Imprint: https://www.eurofinsgenomics.eu/imprint/ Privacy Note: https://www.eurofinsgenomics.eu/privacy/ Next Generation Sequencing, Custom DNA Sequencing, Oligonucleotides, Molecular Biology, Gene Synthesis, Genotyping, and Gene Expression | 1 | 323 |
 | Eurofins Malaysia To be the Global Leader in Testing for Life. Eurofins Scientific is an international life sciences company which provides a unique range of analytical testing services to clients across multiple industries in food, environmental, pharmaceutical and cosmetics. | 1 | 77 |
 | Novalix Novalix is a premier drug discovery CRO Novalix is a premier drug discovery partner to biotech firms and pharmaceutical companies. We apply our exceptional scientific talent and exclusive resources across our platforms to improve the odds of success at each critical pre-clinical stage. The better the science, the better the outcomes. For additional information visit www.novalix.com Target based drug discovery, NMR, SPR, Epigenetic targets, Nuclear receptors, Protein-ligand co-crystal structures by XRD, Native mass spectrometry, FBDD, Organic Chemistry, cryo-electron microscopy, Chemical development, Medicinal chemistry, Structural Biology, in vitro pharmacology, DNA-encoded libraries, Flow chemistry, and Chemical process research Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 36 | 373 |
 | Clean Cells Solution for biologics Clean Cells is a GMP-licensed Contract Development and Manufacturing Organization providing R&D, production and quality control testing services to the biopharmaceutical industry. Our two-part site located in Western France holds an innovative process development platform, BSL2 and BSL3 GMP manufacturing laboratories and analytical areas to develop bespoke assays and perform GMP testing. Clean Cells is part of the Clean Biologics group and benefits from the additional experience of sister company Naobios, a CDMO with considerable experience in the development and manufacture of virus-based products. biosafety testing, Cell Banking and Storage, Viral Clearance, Potency Assay, R&D Contract, Training, … Type: SMB Activities: biotech Technologies: Synthetic Biology | 11 | 123 |
 | PolymerExpert - part of Solabia Group Founded in 2000, PolymerExpert is a French company specialized in the field of polymers. Born from a passion for innovation, the company has become a major player in polymer research and development, particularly in the medical sector (implantable & non-implantable medical devices, biotechnologies, pharmaceuticals), the aeronautics, aerospace, defense sector (composite materials, energetic materials, lubrication), industrial sector (building, energy, sports) or the cosmetics sector (smart raw materials, make-up, skincare, solar). PolymerExpert has filed more than 65 patents and devotes 35% of its revenues to the development of new polymers. Today PolymerExpert keeps innovating in this field by mastering the entire value … Type: SMB Activities: biotech deeptech Technologies: New Materials | 9 | 20 |
 | GENCLIS SA The Transcription Infidelity Technology GENCLIS SA is a privately-held French Biotechnology that discovered a unique biological mechanism referred as to Transcription Infidelity (TI). Transcription Infidelity is a newly discovered and patented mechanism that incresases RNA-DNA sequence divergences (RDD). TI can lead to base substitutions, insertions and deletions. The latter cause translational frameshifts that have important consequences in determining protein immunogenicity. Genclis currently focuses on defining the effects of TI proteins translated from gapped RNA on normal and pathological humoral immunity. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 6 |
 | Provepharm Act to improve life An independent, international specialty pharmaceutical company, Provepharm leverages the potential of mature and well-known molecules to develop innovative solutions that improve patients' lives. Provepharm develops, manufactures, and markets a range of hospital products including antidotes and dyes. Notably, the company is recognized for its expertise in the endoscopic and surgical dye markets. Working closely with healthcare professionals, Provepharm is committed to developing specific services aimed at helping them enhance clinical practices. With a team of over 160 professionals and offices in France, the US and UK, the company markets its products in over 25 countries worldwide … Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 7 | 160 |
 | ELITechGroup - A Bruker Company ELITechGroup is a global leader in in-vitro diagnostics, serving hospitals and diagnostic laboratories in over 100 countries. The company develops, manufactures, and markets a comprehensive range of cutting-edge diagnostic products and solutions, including instruments, reagents, and software. To best meet the needs of its customers, ELITechGroup is organized into three specialized business areas, each dedicated to specific IVD technologies and market segments: Molecular Diagnostics (MDx), Biomedical Systems (EBS), and Microbiology (EM). With a global team of about 600 professionals, ELITechGroup is proud to be part of Bruker Corporation. Bruker’s science and technology leadership puts ELITechGroup’s solutions at the forefront of … Type: SMB Activities: biotech deeptech healthtech manufacturing Technologies: SaaS | 0 | 410 |
 | Aureus Pharma Aureus Sciences focuses on providing solutions to the needs of pharmaceutical and biotech companies to leverage information and knowledge as a decision making tool and to increase the speed and efficiency of their drug discovery and development process. Over the course of 10 years and with a significant investment, the Company has developed a unique Knowledge Production Platform which analyzes, indexes and organizes critical chemical and bioactivity information into databases. Using this platform the Company provides best-in-class, scientific databases and associated software applications for use by researcher involved in the drug discovery and development process.The company's range of products includes … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 2 |
 | SYNCROSOME - Cardiovascular Preclinical expert Cardiovascular & respiratory preclinical expertise since 2000 - ETAP-Lab's cardiology branch of services. At a glimpse SYNCROSOME is the cardiology branch of ETAP-Lab, French preclinical CRO dedicated to in vitro & in vivo efficacy studies for pharmaceutical & biotech companies for over 30 years. Range of services SYNCROSOME is dedicated to cardiovascular & respiratory diseases models like HFrEF, HFpEF, acute myocardial ischemia and arterial/pulmonary arterial hypertension... Models in cardiometabolic disorders are also available. Our added value We can accelerate, derisk and support preclinical development of therapeutics thanks to relevant & translatable in vitro and in vivo models. Our experts aim … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 7 |
 | siTOOLs Biotech GmbH High Specificity Tools for RNAi, rRNA depletion & RNA Interactome Studies. Services: Making Sense of RNAi Screening Data We drive RNA research with tailored molecular tools. We are from Munich and provide researchers with highly complex & advanced genetic tools. Our core expertise is RNA interference, bioinformatics, and RNA research tools for RNA-Seq and Ribo-Seq. Distinguished by their exceptional targeting specificity and efficiency, our gene function analysis tools include - siPOOLTM for reliable gene silencing, raPOOLTM for targeted RNA affinity purification and riboPOOLTM for efficient ribosomal RNA depletion. Our technology combines high complexity oligo pooling (“Pack Hunter” approach), proprietary design … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 9 |
 | Oculyze One of the leading platforms for cloud based quantitative image recognition. Using machine learning and Artificial Intelligence Oculyze has transferred the computer vision software for lab equipment from the table top to the cloud. To prove this revolutionary approach works and is market ready, Oculyze launched the yeast cell counters for breweries and wineries. This device works using a microscope connected to a smartphone and the Oculyze app to upload the images to the cloud where they are analysed by image recognition algorithms. These combine methodical pattern recognition with artificial intelligence and deep learning to offer quantitative real-time image analysis. … Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Deep Learning A.I. - Image Processing A.I. - Machine Learning | 3 | 6 |
 | CYTENA We make the development of modern therapies faster, safer, and more affordable. Join us to create the future of health! We at CYTENA strive to empower our customers to serve patients faster and better. To accelerate workflows and bring new insights into biotherapeutic drug development, we provide precise control of individual cells through automation and microtechnology. Our instruments offer automated isolation of single cells with assurance of clonality and selection based on cell morphology. We can isolate many common cell types including bacteria. Our high viability rates make our instruments compatible with cell line development, single cell analysis, and other … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 1 | 67 |
 | Deep Lens (acquired by Paradigm) Accelerating clinical trial matching in oncology Deep Lens is a digital healthcare company focused on enabling faster recruitment of the best-suited cancer patients for clinical trials at the time of diagnosis using VIPER. Deep Lens’ AI-driven cloud platform gives care teams, trial coordinators and oncologists visibility into all available trials and the ability to collaborate on groundbreaking cancer research across all cancer types. Artificial Intelligence, Pharmaceuticals , Cancer Research, Oncology, and Pathology Type: Startup Activities: biotech deeptech healthtech Technologies: A.I. | 6 | 6 |
 | Olaris, Inc Removing the Guesswork from Medicine Olaris is a precision medicine company leveraging metabolomics and machine learning for the discovery and development of its myOLARISTM diagnostics products, which aim to optimize treatments and outcomes for individual patients. Metabolite diagnostics empower therapeutic selection, treatment effectiveness monitoring, disease diagnosis, and target identification across indications and therapeutics areas, including oncology, solid-organ transplant, and neurodegeneration. Our mission is to remove the guesswork from medicine. Diagnostics, Machine Learning, Metabolomics, NMR, Mass Spectrometry, Statistics, Transplant, and Oncology Type: Startup Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning | 1 | 15 |
 | Murrieta Genomics Launching the Next Great Genomic Startups Murrieta Genomics is dedicated to advancing the use of genomic sequencing in precision medicine, agriculture, forensics, veterinary and direct to consumer applications by offering entrepreneurs access to the specialized equipment, know-how and mentors that can transform research into commercial enterprise. We are a true incubator, offering dedicated bench space to fledgling companies at basically zero cost, helping them to define their business model and validate their science, and then investing in the companies that “graduate” the incubator. We are located in the 16,000 square foot Murrieta Innovation Center in Southern California, in close proximity … | 1 | 7 |
 | Greenpharma S.A.S. From Nature to market Who we are : Greenpharma is a CRO SME of 12 people, specialised in natural compound studies for cosmetic, food and pharmaceutical industries. Built around an innovative technological platform, Greenpharma succeeded to gather expertise in wide and complementary fields such as chemoinformatic, pharmacognosy, medicinal & analytical chemistry, pilot scale extraction and formulation. This has led to a unique know-how in natural compound & extract selection, extract purification, metabolite measurement, homology modelling, virtual screening (e.g. SelnergyTM), lead optimisation, ADMET prediction and database building. Greenpharma approach has led to several patents on bioactive (natural or synthetic) molecules and … Type: SMB Activities: biotech deeptech Technologies: Bio sourced materials | 4 | 16 |
 | Ademtech Our innovative technology from French research (CNRS Bordeaux) makes it possible to manufacture monodisperses (CV & LT; 20 %), very magnetic (70 %), calibrated 100 to 500 nm (+/- 10 nm), providing a high surface (5 to 25 m2/g). These magnetic balls are stable, sensitive and quickly separable under magnetic field. These particles are particularly well suited to be integrated into microfluidic devices. Their surface is, and can be, functionalized by the grafting of molecules of biological interest, in order to capture, isolate and separate, analyze or purify biological entities (molecules, oligonucleotides, cells, viruses) in a total sample. The main … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 0 | 29 |
 | Sartorius Polyplus We power your science Sartorius Polyplus is a leading upstream solutions provider for advanced biological and cell and gene therapy production from research to commercial scale. An innovator in nucleic acid delivery, the legacy portfolio features process-centric transfection reagents, kits, and support services. Custom plasmid vector design was integrated into the offer in 2022 as a first measure to expanding the products and services portfolio to help customers (or the industry) optimize process economics while meeting strict scientific and regulatory standards. We wanted to share that we will not be actively posting or engaging on this LinkedIn account. … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 111 |
 | ATLANTIC BONE SCREEN Your partner for preclinical research in Osteoarticular diseases, Inflammation, Musculoskeletal disorders and Oncology Atlantic Bone Screen is a leading CRO (« Contract Research Organization ») specialized in high-quality preclinical evaluation services in the field of bone and joint diseases and more particularly in bone diseases from tumor origin. Thanks to its high expertise, Atlantic Bone Screen also evaluates biomaterials, either for orthopedic or dental applications. We provide high-quality services to support the characterization of drug candidates, nutraceuticals, biomaterials,... Located in Nantes, North-West of France and created in 2005 by Ronan LE BOT, CEO of the company, Atlantic Bone Screen puts … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 7 | 25 |
 | Just - Evotec Biologics Designing and applying innovative technologies to dramatically expand global access to biotherapeutics. Just – Evotec Biologics, wholly owned by Evotec SE, is a first-to-industry biologics platform that leverages AI/ML technologies and world-leading molecular design, cell line development, process intensification and continuous manufacturing strategies to advance biotherapeutics from discovery through clinical stages to commercial launch. The Just – Evotec Biologics team combines deep industry experience in the fields of data, protein, process, and manufacturing sciences including automation with highly integrated and flexible capabilities to break through the scientific and economic barriers associated with the development of protein therapeutics. Our focus is … Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 6 | 611 |
 |  International Symposium on Minimal Residual Cancer A great opportunity to share information on the most recent developments in oncology, immunology and liquid biopsy. The 2025 meeting in Nice meeting is a great opportunity to gather for three days and share information on the most recent technical developments, clinical trials and latest breaking news with leading researchers in the oncology, immunology and liquid biopsy fields. The 2025 meeting in Nice is supported by the European Liquid Biopsy Society (ELBS), a large consortium of institutions from academia and industry with the vision of bringing liquid biopsy assays into clinical practice. Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 0 | N/A |
 | SFOG The French Society of Oncology-Gynecology The S.F.O.G. As its name suggests, is a national company that brings together specialists involved in the treatment of gynecological cancers (except breast cancer). Type: NGO, Think-tanks, Ed, & Culture Activities: biotech | 0 | 8 |
 | SkinCeuticals Now part of the L'Oréal group brands portfolio, our mission at SkinCeuticals is to improve skin health. Dedicated to this purpose, we make one simple promise—to provide advanced skincare backed by science. Born from decades of skin cancer research that led to pivotal breakthroughs in antioxidants, our high potency formulas are concentrated in pure actives and proven to penetrate optimally into skin. Made in the USA, our clinical skincare is used by dermatologists, plastic surgeons, and medi-spas for daily homecare and to complement aesthetic procedures. We formulate to correct signs of aging, protect healthy skin, and prevent future damage. Cosmeceutical | 1 | 347 |
 | Genoscience Pharma Innovating to Disrupt Cancer Treatment Genoscience Pharma is a French biotech company developing unique small molecules in Oncology. This is the first clinical stage company ever with unique lysosomotropic agents assessed in global clinical trials. For more information, please visit our website, or call us +33 4 91 26 99 50. Liver, Oncology, Clinical Development, Preclinical Development, Discovery, Research & Development, Intellectual Property, Drug Development, and Small Molecule Type: SMB Activities: biotech deeptech manufacturing Technologies: Synthetic Biology | 6 | 4 |
 | BioFeyn BioFeyn is a life sciences company, pioneering advancements in nutrient, medicine, and vaccine delivery to improve food systems and sustainability. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 6 | 2 |
 | XenTech Premium quality preclinical oncology CRO, pioneering the PDX technology for more than 16 years. XenTech is Biotech/Contract Research Organization (CRO) dedicated to translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates (PDX, CDX,...) In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets. patient-derived tumor xenograft models, oncology, biomarkers, efficacy preclinical studies, PDX, CDX, in vivo, and in-vitro assays Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 4 | 38 |
 | Circuit Clinical An IRO committed to better access to clinical research, the development of new medicines, and health equity. Circuit Clinical, one of the fastest-growing research networks in the USA, is dedicated to empowering patients to choose clinical research as a care option through improved access to clinical trials. Committed to transforming the experience of finding, choosing, and participating in clinical research for physicians and their patients, Circuit provides clinical research services through traditional, hybrid, and decentralized community-based site models and their MD Prescreen service that optimizes patient referrals. Learn more at circuitclinical.com Clinical Research Enrollment Solutions, Patient Recruiting Services, Clinical Site … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 11 | 102 |
 | HP Health Solutions For more information, please visit www.gna-bio.com Laser PCR, Molecular Diagnostics, OEM, Molecular Technology, Biosecurity, Life Sciences, Food Safety, Nucleic Acid Amplification, Molecular Assays, Biotechnology, and Nanotechnology Type: Startup Activities: deeptech biotech nanotech Technologies: Synthetic Biology | 1 | 32 |
 | BIO-LUTIONS Renaturing the World of Materials BIO-LUTIONS is pioneering the dry molding production technology to create sustainable packaging solutions made in Germany. Our fibre-based packaging products are completely recyclable (CEPI certification) and an affordable and scalable alternative to single-use plastic. Circular Economy Type: Startup Activities: agritech biotech deeptech Technologies: Bio sourced materials | 0 | 12 |
 | Association Ruban Rose Together, let's fight against breast cancer. Each year in October, the Ruban Rosa association and its partners inform and sensitize on breast cancer and organize various actions to finance pink ribbon prices in favor of research and the fight against breast cancer. Since 2003, more than 8 million euros have been donated to basic and clinical research, as well as work concerning the improvement in the quality of life of patients. Type: NGO, Think-tanks, Ed, & Culture Activities: biotech | 46 | 10 |
 | CLARA - Cancéropôle Lyon Auvergne Rhône-Alpes The goal of the Cancéropôle (cancer cluster) Lyon Auvergne Rhône-Alpes (CLARA) is to structure and facilitate cancer research in the French Rhône-Alpes Auvergne inter region by bringing together academic, clinical and industrial strengths in order to develop a network with a European dimension. CLARA is distinct from the six other French cancéropôles due to its amplitude of funding by local authorities. This particular feature confers strong economic objectives, on top of the objectives related to scientific excellence and public health as presented in the French Cancer Plans. An important feature of CLARA’s strategy is to promote cancer research applications with … Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 55 | 17 |
 | Seed Therapeutics Seed Therapeutics is pioneering the science of improving human health by creating “molecular glues”: novel therapeutics that degrade disease-causing proteins that have heretofore remained “undruggable.” Through ongoing collaborations with world-leading academic experts in the field, and in partnership with seasoned drug development and commercialization experts, Seed Therapeutics is establishing a growing pipeline of exciting drug candidates on a path to clinical and commercial success. Our mission is to positively impact human health by creating novel protein degradation therapeutics for the treatment of severe diseases for which health care professionals currently have limited options to offer to patients. Biotechnology, Biotherapeutics, Cell … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 10 | 19 |
 | Schrödinger Transforming drug discovery and materials research Schrödinger’s industry-leading computational platform facilitates the research efforts of biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger also has wholly-owned and collaborative drug discovery programs in a broad range of therapeutic areas. Schrödinger is deeply committed to investing in the science and talent that drive its computational platform. Schrödinger was founded in 1990 and is engaged with customers and collaborators in more than 70 countries. We welcome you to visit our blog at www.extrapolations.com. Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 997 |
 | Sangamo Therapeutics, Inc. We're committed to translating our ground-breaking science into genomic medicines that transform patients’ lives. For Sangamo Therapeutics, science is a means to develop new medicines with the potential to transform the lives of patients living with serious genetic diseases. Our scientists are leaders in the discovery, research and development of technologies enabling gene-based therapeutic development. Currently we are conducting clinical trials, including the first ever in vivo human genome editing studies. To learn more about Sangamo, visit the our website at www.sangamo.com. Biotechnology, Genome Editing, Gene Therapy, MPS II, MPS I, Hemophilia A, Hemophilia B, Beta Thalassemia, Gene Therapy, Fabry, … Type: SMB Activities: biotech deeptech Technologies: Synthetic Biology | 9 | 283 |
 | Medicrea Pioneering the digital transformation of spinal surgery through A.I., predictive modeling and patient-specific implants. Through the lens of predictive medicine, MEDICREA® leverages its proprietary software analysis tools with big data and machine learning technologies supported by an expansive collection of clinical and scientific data. The Company is well-placed to streamline the efficiency of spinal care, reduce procedural complications and limit time spent in the operating room. Operating in a $10 billion marketplace, MEDICREA® is a Small and Medium sized Enterprise (SME) with 210 employees worldwide, which includes 50 who are based in the U.S. The Company has an ultra-modern manufacturing … Type: SMB Activities: biotech deeptech healthtech manufacturing Technologies: 3D Printing A.I. A.I. - Machine Learning Synthetic Biology | 1 | 73 |
 | Keyrus Life Science The C2RO that helps connect Industry Expertise, Life Data Sciences and Digital Enablement. Keyrus Life Science is a Connected Contract Research Organization (C2RO), active for almost 25 years internationally, and part of the Keyrus group, an expert in data and digital solutions. Combining in-depth scientific and industry expertise, a deep understanding of life data sciences, and the integration of cutting-edge digital technologies, Keyrus Life Science optimizes the conduct of clinical trials and RWE projects, bringing greater agility and reliability, increasing their resilience and performance, and accelerating their execution. Keyrus Life Science supports life science industrials, such as the Pharmaceutical, Biotech … Type: SMB Activities: biotech deeptech healthtech Technologies: Data Analytics | 2 | 220 |
 |  Perpetual Biotechnologies Founded in 2015, as a renewable clean technology company, our mission is to develop sustainable algae derived products and ideas that will embrace the nature and help humanity. Algae, Nutraceuticals, Cosmetics, Pharmaceuticals, and Cleantech Type: Startup Activities: cleantech greentech biotech deeptech Technologies: Decarbonization | 0 | 2 |
 | Tetrahedron SAS The goal of Tetrahedron is to help maintain or restore a healthy life by designing and developing new active ingredients for cosmeceutical, nutritional, biomedical and therapeutical applications. These ingredients may be natural compounds, for which Tetrahedron develops new and sustainable synthesis processes allowing an industrial production of these compounds, or novel molecules derived from natural compounds, therefore providing proprietary compounds. Oxidative stress, Free radical biology, Antioxidant, Sulfur and selenium chemistry, Process development, Ergothioneine, Green chemistry, Sustainable chemistry, and Rare sulfur-containing amino acids Type: SMB Activities: manufacturing biotech deeptech Technologies: Synthetic Biology | 0 | 3 |
 | LexaGene Life Sciences LexaGene’s MiQLab® System— For BioPharma - Automated Bioburden Testing LexaGene Life Sciences is an early-stage company focused on servicing the biopharmaceutical industry by developing advanced microbial testing solutions. Bioburden Testing, Microbial Contamination Testing, and BioPharma Sterility Testing | 0 | 9 |
 | ALYATEC Research and Expertise in Environmental Diseases ALYATEC is a CRO and clinical trial center conducting clinical trials related to allergic and respiratory diseases. We evaluate the efficacy and safety of all kind of solutions intended for allergic asthma, rhinitis, conjunctivitis, atopic dermatitis, rhinosinusitis, severe asthma and food allergy: drugs, medical devices, air purifiers, dietary supplements, face masks, homeopathy ... We have a large database of patients and a network of local physicians offering high patients' recruitment capabilities and deep expertise in clinical data collection as an investigational site. We can also use this database to conduct real-world studies (RWE/RWD). In … Type: SMB Activities: deeptech biotech healthtech Technologies: Synthetic Biology | 3 | 9 |
 | Urosphere Your partner in uro-genital pre-clinical research UROSPHERE is a leading Contract Research Organization specializing in preclinical urogenital, gastro-intestinal and oncological pharmacology studies. We provide the pharmaceutical and biopharmaceutical industries with a unique experimental research platform combining both in vivo models and in vitro assays on human and animal tissues. Innovation, Uro-genital pathologies, Oncology, PDX models, Organoids, CRO, Preclinical Research, Pharmacology, Drug development, Gastrointestinal pathologies, Experimental models, Pain, and Inflammation Type: SMB Activities: deeptech biotech Technologies: Synthetic Biology | 3 | 20 |
 | ACOBIOM Biomarkers & Diagnostics for Precision Medicine Acobiom is specialized in the identification of new Biomarkers and in the development of innovative Diagnostics in Translational Research and Precision Medicine. The company provides also customized services in genomics, transcriptomics, bioinformatics and biostatistics (data science), thanks to its technology platform and its scientific expertise. For more information about Acobiom, please contact the company by email: busdev@acobiom.com, or visit its website: www.acobiom.com. Biomarker, Diagnostics, Companion diagnostics, Bioinformatics, Alzheimer, Pancreatic cancer, Precision medicine, Personalized medicine, biostatistics, artificial intelligence, biomarkers, targeted therapy, cancer, data science, breast cancer, and lung cancer Type: SMB Activities: biotech deeptech Technologies: A.I. A.I. - Machine Learning | 6 | 7 |
 | BIONOV Sector: Pharmaceutical industry - Biotechnology Bionov is an independent young SME created in 1999. This company, based in Avignon, has the purpose of the development, manufacturing and quality control of health ingredients obtained from the melon. The strategic axes of the company can be summed up around the following points: Development of innovative, original and high quality products Valuation and protection of specific know -how Control of technical means of production and control Flexibility and responsiveness in the face of customer and market requests. Development of scientific partnerships to validate the interest of products Human resources (10 people) and means … Type: SMB Activities: manufacturing biotech | 0 | 17 |
 | Okomera Automated 3D organoid screening technology We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity Type: Startup Activities: biotech deeptech healthtech Technologies: Synthetic Biology | 36 | 27 |
 | Rime Bioinformatics Making high performance bioinformatics accessible. Rime Bioinformatics is a research and development biotechnology company with a focus on bioinformatics. We develop services to speed up medical, agronomic and veterinary research. Our technologies grant in-depth view of bacterial and bacteriophage genomes, which is an essential prerequisite in the R&D process that leads a phage to market. We work hard to make high-performance bioinformatics accessible and promote a safe use of phage therapy for the patients and the environment ! Bioinformatics, Phage, Bacteriophage, Genomics, Bacteria, Phage Therapy, and metagenomics Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 2 | 4 |
 | PEP-Therapy Innovative peptides as targeted therapies for oncology PEP-Therapy is a clinical-stage biotechnology company developing first-in-class peptides as targeted therapies in oncology. PEP-010, first drug candidate, is a pro-apoptotic agent which has demonstrated anti-tumor efficacy in a number of pre-clinical models and a good safety profile. PEP-010 is currently evaluated in a Phase Ia/b clinical trial in patients with recurrent and/or metastatic solid tumors. PEP-Therapy was founded in 2014 and builds on research results from Institut Curie and Sorbonne University. The company is backed by international investors. cell penetrating peptide, protein-protein interaction, targeted therapies, oncology, clinical trial, and cancer Type: Startup Activities: deeptech biotech Technologies: Synthetic Biology | 7 | 15 |
 | Microphyt Fostering a Blue Future ! Created in 2007 near Montpellier-France, Microphyt develops and markets unique microalgae-based bioactives using breakthrough technologies and processes. Developed over 10 years, and endorsed by key customers, partners and investors, these bioactives are addressing the nutraceutical & cosmetic industry sectors. photobioreactor, microalgae, nutrition, biotechnology, Blue Future, nutraceuticals, Made in France, Cosmetics, innovation, better living, patented technology, natural ingredients, and bioactive compounds Type: Startup Activities: biotech deeptech Technologies: Bio sourced materials | 30 | 65 |
 | GenSight Biologics Applying pathbreaking science to transform the lives of patients with severe retinal neurodegenerative diseases GenSight Biologics is a clinical-stage biotechnology company discovering and developing novel therapies for neurodegenerative retinal diseases and diseases of the central nervous system. GenSight Biologics’ pipeline leverages two core technology platforms, the Mitochondrial Targeting Sequence (MTS) and optogenetics for retinitis pigmentosa, to help preserve or restore vision in patients suffering from severe degenerative retinal diseases. GenSight Biologics’ lead product candidate, GS010, is in Phase III trials in Leber’s Hereditary Optic Neuropathy (LHON), a rare mitochondrial disease that leads to irreversible low vision and legal blindness in … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 16 | 34 |
 | Affilogic Discovering and developing Nanofitins® through collaboration with worldwide pharma industry leaders Affilogic is a private biotech company specialised in discovering and developing Nanofitins® through early-stage collaborations with worldwide industry leaders in the pharmaceutical sector. These affinity proteins are potent antibody-mimetics, exhibiting a high affinity and specificity for capture, targeting and interacting with biomolecules. Each Nanofitin® is 20 times smaller than an antibody (7 kDa) and demonstrates hyper stability. Nanofitins are easily combined with each other, antibodies and other biomolecules by simple, rapid and proven methods to design an ideal targeted molecule. Affilogic has designed Nanofitins® against 60+ targets to date, … Type: Startup Activities: biotech deeptech Technologies: Synthetic Biology | 5 | 37 |
 | ONLYNNOV Insurance broker for innovative companies : "we insure Frenchtech Worlwide" Insurance broker specializing in Innovative Compagnies risk management and insurance. We created a range of insurance products specificaly for your univers : - onlyNUM for software editors, cloud provider, digital services providers and web economy - onlyMED for Medical industries, life sciences, Medtech and devices, Biotech, Pharmaceuticals - onlyIOT for the Internet of Things, Mecatronics and Robotics Assurance des entreprises innovantes, Biotech, Medtech, Dispositifs Médicaux, Pharma, Numérique, Web, Cloud, Editeurs de Logicels, ESN SSII, objets connectés, Robotique, Robots, Mécatronique, Véhicules autonomes, Nouvelles mobilités, RC promoteur de recherche biomédicale, Responsabilité des … Type: Startup Activities: insurtech deeptech it services healthtech biotech Technologies: IoT Robotics | 27 | 11 |
 | LEO Pharma France Leo Pharma helps patients have healthy skin. By offering therapeutic solutions in more than 100 countries around the world, Leo Pharma helps people manage their skin problems. Founded in 1908, the pharmaceutical company is fully owned by the Leo Foundation. For decades, Leo Pharma has dedicated his research and development to drugs and solutions for people with skin diseases. Leo Pharma's parent company is based in Denmark and has around 5,000 employees worldwide. For more information, go to www.leo-pharma.com and www.leo-pharma.fr Dermatology, thrombosis, psoriasis, and atopic dermatitis Type: NGO, Think-tanks, Ed, & Culture Activities: biotech deeptech | 8 | 197 |
 | From Fauna For the People | For the Animals | For the World From Fauna is an international 501c3 nonprofit spreading awareness on cultivated meat (real meat made from cells instead of animals). Cellular Agriculture, Biotechnology, Agriculture, Cell Agriculture, CAS, Food Technology, and Biomaterials Type: NGO, Think-tanks, Ed, & Culture Activities: agritech biotech deeptech | 0 | 7 |
 | New Incentives New Incentives provides small cash incentives to increase childhood vaccinations and cost-effectively save lives. As a GiveWell top charity, New Incentives is dedicated to doing the most good per dollar donated. We are a US-based NGO that provides small cash incentives to caregivers (totalling approximately US$11) to vaccinate their infants against deadly, yet preventable diseases. We operate in northern Nigeria – a region with one of the lowest childhood vaccination rates in the world. We are recruiting: https://new-incentives.breezy.hr/ public health, immunizations, ngo, cash transfers, demand creation, Nigeria, Effective Altruism, GiveWell, vaccinations, startup, and health system strengthening Type: NGO, Think-tanks, Ed, & Culture Activities: biotech | 4 | 612 |